Maintenance Therapy With Subcutaneous Bortezomib

Summary

This is a multicenter, randomized, open label study designed to evaluate the efficacy and safety of prolonged treatment with bortezomib twice monthly and dexamethasone after a salvage treatment containing bortezomib for relapsed or refractory multiple myeloma patients.

Timeline

Start

2013-11

Primary completion

2021-04

Completion

2023-09-07

Drugs

Indications